INTECH Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
INTECH Investment Management's GILD Position: Q2 2026 in Review
INTECH Investment Management increased its Gilead Sciences (GILD) stake by 22% in Q2 2026, buying an estimated $3.24M and bringing the position to 135,233 shares worth $17.1M. The position accounts for 0.16% of the portfolio, ranked #98.
INTECH Investment Management first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $139M in Q1 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- INTECH Investment Management held 135,233 shares of Gilead Sciences worth $17.1M as of Q2 2026.
- INTECH Investment Management bought 24,615 Gilead Sciences shares in Q2 2026, an estimated $3.24M.
- Gilead Sciences made up 0.16% of INTECH Investment Management's portfolio in Q2 2026, its #98 holding.
- INTECH Investment Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
- INTECH Investment Management's Gilead Sciences position peaked at $139M in Q1 2023.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.